Shattuck Labs, Inc.
Support and Resistance Levels
Past performance
News About STTK
All events for STTK
All deals for STTK
Financial Ratios
Financial Statements
STTK vs Sector & Peers
About Shattuck Labs, Inc.
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas. Website shattucklabs.com
Headquarters Austin, TX, US